These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats. Tabata Y; Chang TM Trans Am Soc Artif Intern Organs; 1980; 26():394-9. PubMed ID: 7245521 [No Abstract] [Full Text] [Related]
3. The effects of hemoperfusion using coated charcoal or tyrosinase artificial cells on middle molecules and tyrosine in brain and serum of hepatic coma rats. Shi ZQ; Chang TM Trans Am Soc Artif Intern Organs; 1982; 28():205-9. PubMed ID: 6819667 [No Abstract] [Full Text] [Related]
4. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats. Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006 [No Abstract] [Full Text] [Related]
5. Artificial liver. Matsushita M; Nosé Y Artif Organs; 1986 Oct; 10(5):378-84. PubMed ID: 3539076 [No Abstract] [Full Text] [Related]
6. Charcoal hemoperfusion. Plus ça change, plus c'est la même chose. Berk PD; Goldberg JD Gastroenterology; 1988 May; 94(5 Pt 1):1228-30. PubMed ID: 3350293 [No Abstract] [Full Text] [Related]
7. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review. Chang TM Semin Liver Dis; 1986 May; 6(2):148-58. PubMed ID: 3529408 [TBL] [Abstract][Full Text] [Related]
9. [Achievements in the treatment of acute hepatic insufficiency]. Kozakiewicz H Pol Tyg Lek; 1981 Apr; 36(15):537-9. PubMed ID: 7024943 [No Abstract] [Full Text] [Related]
10. In vitro adsorption of possible aetiological factors of hepatic encephalopathy. Chamuleau RA; Schoemaker LP; Smit EM Int J Artif Organs; 1979 Nov; 2(6):284-8. PubMed ID: 389835 [TBL] [Abstract][Full Text] [Related]
11. Fulminant hepatic failure and artificial liver support. Williams R; Ede R; Gimson AE; Hughes RD Indian J Gastroenterol; 1985 Jul; 4(3):177-80. PubMed ID: 3848413 [No Abstract] [Full Text] [Related]
12. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure. Dixit V; Chang TM Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688 [TBL] [Abstract][Full Text] [Related]
13. The present position of liver support therapy. Hobbs KE Resuscitation; 1973 Apr; 2(1):51-5. PubMed ID: 4577918 [No Abstract] [Full Text] [Related]
14. [Artificial system sustaining liver function in hepatic coma]. Shurkalin BK Anesteziol Reanimatol; 1978; (2):70-4. PubMed ID: 677519 [No Abstract] [Full Text] [Related]
15. [Application of an artificial liver system in hastening patients' recovery from the comatose state in hepatic coma]. Amano I; Kano H Kango Tenbo; 1977 Sep; 2(9):69-73. PubMed ID: 242730 [No Abstract] [Full Text] [Related]
16. A 1978 perspective of hemoperfusion. Chang TM Artif Organs; 1978 Nov; 2(4):359-62. PubMed ID: 743005 [TBL] [Abstract][Full Text] [Related]
17. [New treatment possibilities of terminal liver coma]. Fischer M; Erhardt W; Krueger P; Maurer P; Stock M; Stötter L Med Klin; 1974 May; 69(22):975-8. PubMed ID: 4603094 [No Abstract] [Full Text] [Related]
18. An adsorption and filtration technique for temporary hepatic assistance. Agishi T; Teraoka S; Fuchinoue S; Honda H; Ota K ASAIO Trans; 1988; 34(4):969-71. PubMed ID: 3219259 [No Abstract] [Full Text] [Related]
19. Use of artificial liver support. Williams R; Ede R; Hughes R Int J Clin Pharmacol Res; 1985; 5(6):381-7. PubMed ID: 3005180 [TBL] [Abstract][Full Text] [Related]
20. [Nursing of a patient with fulminant hepatitis--on the patient treated with plasma exchange and an artificial liver]. Fujiwara S; Okawa K; Mizoguchi R; Watanabe K Kango Tenbo; 1977 Sep; 2(9):48-52. PubMed ID: 242726 [No Abstract] [Full Text] [Related] [Next] [New Search]